Liam Ratcliffe

Insider Reports History

Entity
Individual
Location
C/O Access Industries, Inc, 40 West 57 Th St, 28 Th Floor, New York, New York
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Liam Ratcliffe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Director Common Stock 186 K $2.97 M $16.00 Dec 16, 2021 Indirect
ARVINAS, INC. Director Stock Option (right to buy) 10.2 K $163 K $16.00 Jun 16, 2022 Direct
Passage BIO, Inc. Director Director Stock Option (Right to Buy) 16.9 K May 27, 2021 Direct
Disc Medicine, Inc. Director Stock Option (Right to Buy) 10 K Jun 12, 2024 Direct
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10 K Jun 26, 2024 Direct

Insider Reports Filed by Liam Ratcliffe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELYM Eliem Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
IRON Disc Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
IRON Disc Medicine, Inc. Jun 9, 2023 1 $0 4 Jun 9, 2023 Director
ELYM Eliem Therapeutics, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 1 $0 4 Jan 3, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 Director
ARVN ARVINAS, INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director
ARVN ARVINAS, INC. Dec 14, 2021 8 -$23.8 M 4 Dec 16, 2021 Director
ARVN ARVINAS, INC. Nov 10, 2021 13 -$11.5 M 4 Nov 15, 2021 Director
ARVN ARVINAS, INC. Nov 5, 2021 22 -$15.5 M 4 Nov 9, 2021 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director
ARVN ARVINAS, INC. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
PASG Passage BIO, Inc. May 27, 2021 1 $0 4 May 28, 2021 Director